Payment overview · 2025
General Payments
4 reported records · 3 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Internal Medicine · PORT ORANGE, FL · NPI 1790756765
Verified facts
CMS Open Payments records show Mario Cucchiarella, M.D. received $80.38 in general payments during 2025 across 4 reported records.
Exact Sciences Corporation accounted for 49.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
4 reported records · 3 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $39.94 | 49.7% | 2 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $25.32 | 31.5% | 1 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $15.12 | 18.8% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $80.38 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $39.94 | 2 | 2025 |
Source payment records
|
|||||
| Indigo System Normalized: indigo system |
Device | Penumbra, Inc. | $25.32 | 1 | 2025 |
Source payment records
|
|||||
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $15.12 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 343 | 55 |
| Losartan Potassium | Losartan Potassium | 325 | 84 |
| Levothyroxine Sodium | Levothyroxine Sodium | 317 | 87 |
| Lisinopril | Lisinopril | 294 | 79 |
| Amlodipine Besylate | Amlodipine Besylate | 279 | 82 |
| Atorvastatin Calcium | Atorvastatin Calcium | 266 | 78 |
| Alprazolam | Alprazolam | 206 | 46 |
| Lorazepam | Lorazepam | 191 | 35 |
| Metformin Hcl | Metformin Hcl | 184 | 55 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 179 | 54 |
| Furosemide | Furosemide | 178 | 55 |
| Omeprazole | Omeprazole | 171 | 52 |
| Metoprolol Tartrate | Metoprolol Tartrate | 156 | 47 |
| Simvastatin | Simvastatin | 141 | 41 |
| Ezetimibe | Ezetimibe | 135 | 39 |
| Temazepam | Temazepam | 135 | 23 |
| Tramadol Hcl | Tramadol Hcl | 127 | 35 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 117 | 41 |
| Metformin Hcl Er | Metformin Hcl | 115 | 33 |
| Sertraline Hcl | Sertraline Hcl | 114 | 30 |
| Hydrochlorothiazide | Hydrochlorothiazide | 108 | 38 |
| Pantoprazole Sodium | Pantoprazole Sodium | 95 | 32 |
| Gabapentin | Gabapentin | 89 | 27 |
| Pravastatin Sodium | Pravastatin Sodium | 89 | 27 |
| Famotidine | Famotidine | 86 | 30 |
| Zolpidem Tartrate | Zolpidem Tartrate | 85 | 13 |
| Potassium Chloride | Potassium Chloride | 81 | 23 |
| Glimepiride | Glimepiride | 77 | 26 |
| Eliquis | Apixaban | 71 | 20 |
| Lovastatin | Lovastatin | 68 | 19 |
| Azithromycin | Azithromycin | 67 | 47 |
| Diclofenac Sodium | Diclofenac Sodium | 67 | 25 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 64 | 18 |
| Diazepam | Diazepam | 62 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 62 | 21 |
| Fenofibrate | Fenofibrate Nanocrystallized | 59 | 17 |
| Trazodone Hcl | Trazodone Hcl | 59 | 17 |
| Clonazepam | Clonazepam | 58 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 58 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 58 | suppressed |
| Atenolol | Atenolol | 52 | 15 |
| Allopurinol | Allopurinol | 47 | 15 |
| Prednisone | Prednisone | 47 | 23 |
| Xarelto | Rivaroxaban | 47 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 46 | 15 |
| Amoxicillin | Amoxicillin | 44 | 18 |
| Tamsulosin Hcl | Tamsulosin Hcl | 43 | 13 |
| Escitalopram Oxalate | Escitalopram Oxalate | 40 | suppressed |
| Metoprolol Succinate | Metoprolol Succinate | 40 | 12 |
| Fluconazole | Fluconazole | 39 | 14 |
| Levofloxacin | Levofloxacin | 39 | 18 |
| Qtern | Dapagliflozin/Saxagliptin Hcl | 39 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 39 | 12 |
| Bydureon Bcise | Exenatide Microspheres | 36 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 34 | 11 |
| Doxycycline Hyclate | Doxycycline Hyclate | 33 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 32 | 11 |
| Enalapril Maleate | Enalapril Maleate | 32 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 31 | 22 |
| Lansoprazole | Lansoprazole | 30 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 29 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 29 | suppressed |
| Synthroid | Levothyroxine Sodium | 29 | suppressed |
| Nifedipine Er | Nifedipine | 28 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 27 | suppressed |
| Telmisartan | Telmisartan | 27 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 26 | suppressed |
| Acyclovir | Acyclovir | 25 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 25 | suppressed |
| Estradiol | Estradiol | 24 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 24 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 23 | suppressed |
| Meloxicam | Meloxicam | 23 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 22 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 22 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 21 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Methocarbamol | Methocarbamol | 20 | 11 |
| Mirtazapine | Mirtazapine | 20 | suppressed |
| Naproxen | Naproxen | 20 | suppressed |
| Carvedilol | Carvedilol | 19 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 19 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 19 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 19 | suppressed |
| Trimethoprim | Trimethoprim | 19 | 13 |
| Cefprozil | Cefprozil | 18 | 15 |
| Cephalexin | Cephalexin | 18 | 12 |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 17 | 11 |
| Finasteride | Finasteride | 17 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 17 | suppressed |
| Pregabalin | Pregabalin | 17 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 16 | suppressed |
| Celecoxib | Celecoxib | 16 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 16 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 16 | suppressed |
| Procto-Med Hc | Hydrocortisone | 16 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 16 | suppressed |
| Trulicity | Dulaglutide | 16 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 15 | suppressed |
| Ibuprofen | Ibuprofen | 15 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 15 | suppressed |
| Spironolactone | Spironolactone | 15 | suppressed |
| Chlorthalidone | Chlorthalidone | 14 | suppressed |
| Methylprednisolone | Methylprednisolone | 14 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 14 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 13 | suppressed |
| Digoxin | Digoxin | 13 | suppressed |
| Glipizide | Glipizide | 13 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 13 | suppressed |
| Memantine Hcl | Memantine Hcl | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Brilinta | Ticagrelor | 12 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 12 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 11 | suppressed |
| Bupropion Xl | Bupropion Hcl | 11 | suppressed |
| Jardiance | Empagliflozin | 11 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 11 | suppressed |
| Mupirocin | Mupirocin | 11 | suppressed |
| Ozempic | Semaglutide | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $80.38 · 4 records | Exact Sciences Corporation | Cologuard Collection Kit, Indigo System, SHINGRIX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error